BackLipella Pharmaceuticals Overview

Lipella Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for LIPO.

Quarterly EBIT

-$1.25B
↑ 14.07% YoY

As of Sep 30, 2025

Annual EBIT (TTM)

-$2.56B
↓ 6.21% YoY

Trailing 12 months ending Sep 30, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin